CVM

$0.00

(

0.00%

)
Quote details

stock

CEL-SCI Corp

NYSE MKT | CVM

7.06

USD

$0.00

(

0.00%

)

At Close (As of Nov 4, 2025)

$56.67M

Market Cap

-

P/E Ratio

-9.13

EPS

$32.70

52 Week High

$1.98

52 Week Low

HEALTHCARE

Sector

CVM Chart

Recent Chart
Price Action

CVM Technicals

Tags:

CVM Earnings

Yearly Income Statement (As of Sep 30, 2024)

Field Value (USD)
Gross Profit -$4M
Total Revenue $0
Cost Of Revenue $4M
Costof Goods And Services Sold $4M
Operating Income -$26M
Selling General And Administrative $7.8M
Research And Development $18M
Operating Expenses $22M
Investment Income Net -
Net Interest Income -$746K
Interest Income -
Interest Expense $746K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $4M
Income Before Tax -$27M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$27M
Comprehensive Income Net Of Tax -
Ebit -$26M
Ebitda -$22M
Net Income -$27M

Revenue & Profitability

Earnings Performance

CVM Financials

yearly Balance Sheet (As of Sep 30, 2024)

Field Value (USD)
Total Assets $27M
Total Current Assets $6.1M
Cash And Cash Equivalents At Carrying Value $4.7M
Cash And Short Term Investments $4.7M
Inventory $1M
Current Net Receivables -
Total Non Current Assets $21M
Property Plant Equipment $17M
Accumulated Depreciation Amortization Ppe -
Intangible Assets $165K
Intangible Assets Excluding Goodwill $165K
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $3.5K
Other Current Assets $298K
Other Non Current Assets -
Total Liabilities $14M
Total Current Liabilities $4.6M
Current Accounts Payable $1.4M
Deferred Revenue -
Current Debt -
Short Term Debt $4.5M
Total Non Current Liabilities $9.5M
Capital Lease Obligations $12M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $12M
Other Current Liabilities -$1.3M
Other Non Current Liabilities $125K
Total Shareholder Equity $13M
Treasury Stock -
Retained Earnings -$514M
Common Stock $638K
Common Stock Shares Outstanding $2M

yearly Cash Flow (As of Sep 30, 2024)

Field Value (USD)
Operating Cashflow -$19M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $4M
Capital Expenditures $95K
Change In Receivables -
Change In Inventory -$173K
Profit Loss -
Cashflow From Investment -$108K
Cashflow From Financing $20M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $24M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$27M

yearly Income Statement (As of Sep 30, 2024)

Field Value (USD)
Gross Profit -$4M
Total Revenue $0
Cost Of Revenue $4M
Costof Goods And Services Sold $4M
Operating Income -$26M
Selling General And Administrative $7.8M
Research And Development $18M
Operating Expenses $22M
Investment Income Net -
Net Interest Income -$746K
Interest Income -
Interest Expense $746K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $4M
Income Before Tax -$27M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$27M
Comprehensive Income Net Of Tax -
Ebit -$26M
Ebitda -$22M
Net Income -$27M

CVM Profile

CEL-SCI Corp Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

CEL-SCI Corporation (CVM) is an innovative biotechnology company focused on advancing immunotherapy solutions for cancer and infectious diseases. Based in Vienna, Virginia, the company is dedicated to developing its lead product candidate, Multikine, which aims to harness the body's immune system to target and destroy tumors. With a robust pipeline and commitment to addressing unmet medical needs, CEL-SCI is positioned to make significant contributions to the field of cancer treatment and beyond.

PTLE
+51.53%
$0.28
MSPR
+27.56%
$0.66
SCNX
+15.35%
$0.81
NVDA
-3.95%
$198.69
BYND
-4.31%
$1.33
ORIS
-0.12%
$0.16
PFE
-1.45%
$24.30
VHAI
0.00%
$0.00
HTZ
+36.23%
$6.73
PLTR
-7.93%
$190.74
ASST
-1.57%
$1.25
GRAB
-4.69%
$5.78
INTC
-6.25%
$37.03
PLUG
-8.36%
$2.52
ONDS
-3.08%
$5.96
CHR
+8.10%
$0.13
DNN
-6.16%
$2.74
WTO
-6.22%
$0.04
TSLA
-5.14%
$444.26
CAPT
+31.77%
$0.66
KVUE
-1.05%
$15.97
NFE
+14.40%
$1.35
BITF
-6.56%
$3.84
YDKG
-3.39%
$0.05
EPWK
+3.60%
$0.07
T
-0.36%
$24.44
ETHD
+20.91%
$5.26
F
-1.69%
$12.79
ACHR
-8.25%
$9.56
SOFI
-4.11%
$29.37
AXDX
-61.36%
$0.03
CIFR
-1.09%
$22.51
GPUS
-7.02%
$0.34
HIMS
-3.60%
$42.79
CMBM
+58.82%
$3.24
BTBT
-7.01%
$3.18
BURU
-7.90%
$0.28
AAL
-5.17%
$12.65
NCLH
-15.28%
$18.79
AMD
-3.69%
$250.05
RGTI
-10.07%
$35.18
BTG
-5.88%
$4.00
RIVN
-5.23%
$12.50
CAN
-14.61%
$1.11
AMZN
-1.84%
$249.32
VALE
-2.13%
$11.94
ADAP
-15.14%
$0.05
MARA
-6.68%
$16.62
AAPL
+0.36%
$270.04
UBER
-5.06%
$94.67
TLRY
-5.34%
$1.24
BAC
-0.03%
$53.54
PLTZ
+16.06%
$6.07
SOUN
-11.57%
$15.13
BMNR
-7.93%
$39.46
IREN
-1.65%
$66.63
NOK
-4.75%
$6.81
SNAP
-4.47%
$7.47
WULF
-6.77%
$15.01
VSEE
+3.03%
$1.02
RXRX
-8.08%
$5.00
NIO
-3.50%
$7.16
RUBI
-11.62%
$0.60
WBD
+1.39%
$22.60
NGD
-8.79%
$6.64
CCL
-9.05%
$26.11
RMBL
+60.50%
$3.21
JOBY
-9.55%
$14.76
ADD
-25.47%
$0.05
NVTS
-14.61%
$10.46
RIG
-1.51%
$3.90
QBTS
-10.12%
$29.74
PLTD
+7.99%
$6.35
SRM
+53.27%
$10.30
CMG
+0.72%
$31.74
SMCI
-6.60%
$47.40
VZ
-0.38%
$39.32
DVLT
-3.26%
$1.78
LUMN
-10.90%
$10.54
HPE
-3.83%
$23.56
AMCR
+0.12%
$7.87
KDLY
-11.88%
$0.78
CDE
-8.71%
$13.82
NAKA
-11.88%
$0.78
CLF
-10.02%
$10.68
APLD
-5.50%
$31.06
GOOGL
-2.17%
$277.54
WLGS
-5.57%
$0.04
UUUU
-4.43%
$17.01
CLSK
-6.88%
$16.22
AGNC
+1.29%
$10.18
NVO
-1.75%
$48.25
RR
-8.78%
$4.05
IONZ
+17.01%
$4.47
CGC
-5.83%
$1.12
DENN
+50.36%
$6.18
CTRA
+5.98%
$25.85
FUBO
+6.35%
$3.68
ETWO
0.00%
$3.30
META
-1.62%
$627.32
PTLE
+51.53%
$0.28
MSPR
+27.56%
$0.66
SCNX
+15.35%
$0.81
NVDA
-3.95%
$198.69
BYND
-4.31%
$1.33
ORIS
-0.12%
$0.16
PFE
-1.45%
$24.30
VHAI
0.00%
$0.00
HTZ
+36.23%
$6.73
PLTR
-7.93%
$190.74
ASST
-1.57%
$1.25
GRAB
-4.69%
$5.78
INTC
-6.25%
$37.03
PLUG
-8.36%
$2.52
ONDS
-3.08%
$5.96
CHR
+8.10%
$0.13
DNN
-6.16%
$2.74
WTO
-6.22%
$0.04
TSLA
-5.14%
$444.26
CAPT
+31.77%
$0.66
KVUE
-1.05%
$15.97
NFE
+14.40%
$1.35
BITF
-6.56%
$3.84
YDKG
-3.39%
$0.05
EPWK
+3.60%
$0.07
T
-0.36%
$24.44
ETHD
+20.91%
$5.26
F
-1.69%
$12.79
ACHR
-8.25%
$9.56
SOFI
-4.11%
$29.37
AXDX
-61.36%
$0.03
CIFR
-1.09%
$22.51
GPUS
-7.02%
$0.34
HIMS
-3.60%
$42.79
CMBM
+58.82%
$3.24
BTBT
-7.01%
$3.18
BURU
-7.90%
$0.28
AAL
-5.17%
$12.65
NCLH
-15.28%
$18.79
AMD
-3.69%
$250.05
RGTI
-10.07%
$35.18
BTG
-5.88%
$4.00
RIVN
-5.23%
$12.50
CAN
-14.61%
$1.11
AMZN
-1.84%
$249.32
VALE
-2.13%
$11.94
ADAP
-15.14%
$0.05
MARA
-6.68%
$16.62
AAPL
+0.36%
$270.04
UBER
-5.06%
$94.67
TLRY
-5.34%
$1.24
BAC
-0.03%
$53.54
PLTZ
+16.06%
$6.07
SOUN
-11.57%
$15.13
BMNR
-7.93%
$39.46
IREN
-1.65%
$66.63
NOK
-4.75%
$6.81
SNAP
-4.47%
$7.47
WULF
-6.77%
$15.01
VSEE
+3.03%
$1.02
RXRX
-8.08%
$5.00
NIO
-3.50%
$7.16
RUBI
-11.62%
$0.60
WBD
+1.39%
$22.60
NGD
-8.79%
$6.64
CCL
-9.05%
$26.11
RMBL
+60.50%
$3.21
JOBY
-9.55%
$14.76
ADD
-25.47%
$0.05
NVTS
-14.61%
$10.46
RIG
-1.51%
$3.90
QBTS
-10.12%
$29.74
PLTD
+7.99%
$6.35
SRM
+53.27%
$10.30
CMG
+0.72%
$31.74
SMCI
-6.60%
$47.40
VZ
-0.38%
$39.32
DVLT
-3.26%
$1.78
LUMN
-10.90%
$10.54
HPE
-3.83%
$23.56
AMCR
+0.12%
$7.87
KDLY
-11.88%
$0.78
CDE
-8.71%
$13.82
NAKA
-11.88%
$0.78
CLF
-10.02%
$10.68
APLD
-5.50%
$31.06
GOOGL
-2.17%
$277.54
WLGS
-5.57%
$0.04
UUUU
-4.43%
$17.01
CLSK
-6.88%
$16.22
AGNC
+1.29%
$10.18
NVO
-1.75%
$48.25
RR
-8.78%
$4.05
IONZ
+17.01%
$4.47
CGC
-5.83%
$1.12
DENN
+50.36%
$6.18
CTRA
+5.98%
$25.85
FUBO
+6.35%
$3.68
ETWO
0.00%
$3.30
META
-1.62%
$627.32

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.